Publications
Publications
Peer-reviewed articles
1.) Pai JK, Curhan GC, Cannuscio CC, Rifai N, Ridker PM, Rimm EB. Stability of Novel Plasma Markers Associated with Cardiovascular Disease: Processing within 36 Hours of Specimen Collection. Clin Chem 2002; 48(10): 1781-4.
2.) Knight EL, Rimm EB, Pai JK, Rexrode KM, Cannuscio CC, Manson JE, Stampfer MJ, Curhan GC. Kidney dysfunction, inflammation, and coronary events: a prospective study. J Am Soc Nephrol 2004 Jul;15(7):1897-903.
3.) Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB. Inflammatory Markers and Risk of Coronary Heart Disease in US Men and Women. New Engl J Med 2004;351(25): 2599-610.
4.) Pischon T, Pai JK, Manson JE, Hu FB, Rexrode KM, Hunter D, Rimm EB. Peroxisome Proliferator-Activated Receptor-gamma2 P12A Polymorphism and Risk of Coronary Heart Disease in US Men and Women. Arterioscler Thromb Vasc Biol 2005;25(8):1654-8.
5.) Pai JK, Hankinson SE, Thadhani R, Rifai N, Pischon T, Rimm EB. Moderate Alcohol Consumption and Lower Levels of Inflammatory Markers in US Men and Women. Atherosclerosis 2006 May;186(1):113-20.
6.) Pai JK, Kraft P, Cannuscio CC, Manson JE, Rexrode KM, Albert CM, Hunter D, Rimm EB. Polymorphisms in the CC-Chemokine Receptor-2 (CCR2) and -5 (CCR5) Genes and Risk of Coronary Heart Disease among US Women. Atherosclerosis 2006 May;186(1):132-9.
7.) Asselbergs FW, Pai JK, Pischon T, Manson JE, Rimm EB. Thrombospondin-4 Ala387Pro polymorphism is not associated with vascular function and risk of coronary heart disease in US men and women. Thromb Haemost 2006 Mar;95(3):589-90.
8.) Asselbergs FW, Pai JK, Rexrode KM, Hunter DJ, Rimm EB. Effects of lymphotoxin-alpha gene and galectin 2 gene polymorphisms on inflammatory biomarkers, cellular adhesion molecules, and risk of coronary heart disease. Clin Sci (Lond) 2007 Mar;112(5):291-8.
9.) Pai JK, Manson JE, Rexrode KM, Albert CM, Hunter DJ, Rimm EB. Complement Factor H (CFH) Y402H Polymorphism and Risk of Coronary Heart Disease among U.S. Men and Women. Eur Heart J 2007 Jun; 28(11):1297-303.
10.) Pischon T, Pai JK, Manson JE, Rimm EB. Single Nucleotide Polymorphisms at the Adiponectin Locus with Risk of Coronary Heart Disease in Men and Women. Obesity 2007 Aug; 15(8):2051-60.
11.) Emerging Risk Factors Collaboration. The Emerging Risk Factors Collaboration: Analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies on cardiovascular disease. Eur J Epidemiol 2007 Dec; 22(12):839-869.
12.) Jensen MK, Pai JK, Mukamal KJ, Overvad K, Rimm EB. Common Genetic Variation in the ATP-binding cassette transporter A1, Plasma Lipids, and Risk of Coronary Heart Disease. Atherosclerosis 2007 Nov;195(1);e172-80.
13.) Pai JK, Mukamal KJ, Rexrode KM, Rimm EB. C-Reactive Protein (CRP) Gene Polymorphisms, CRP Levels, and Risk of Incident Coronary Heart Disease in Two Nested Case-Control Studies. PLoS ONE 2008 Jan; 3(1):e1395.
14.) CRP CHD Genetics Collaboration. Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomisation. Eur J Epidemiol 2008; 23(8):531-40.
15.) Mukamal KJ, Pai JK, Jensen MK, Rimm EB. Paraoxonase 1 Polymorphisms and Risk of Myocardial Infarction in Women and Men. Circ J 2009 Jul;73(7):1302-7.
16.) Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009 Nov 11;302(18):1993-2000.
17.) Mukamal KJ, Pai JK, O’Meara ES, Tracy RP, Psaty BM, Kuller LH, Newman AB, Yende S, Curhan GC, Siscovick DS, Rimm EB. CRP gene variation and risk of community-acqured pneumonia. Respirology 2010;15:160–164.
18.) Emerging Risk Factors Collaboration. Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies. Int J Epidemiol. 2010 Oct;39(5):1345-59.
19.) CRP CHD Genetics Collaboration. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ 2011 Feb 15;342:d548.
20.) Pai JK, Mukamal KJ, Rimm EB. Long-term alcohol consumption in relation to all-cause and cardiovascular mortality among survivors of myocardial infarction: the Health Professionals Follow-up Study. Eur Heart J 2012; doi: 10.1093/eurheartj/ehs047. First published online: March 27, 2012
Review Articles
1.) Pai JK. Asymmetric Dimethylarginine as a Marker of Metabolic Dysfunction and Cardiovascular Disease. Current Cardiovascular Risk Reports 2008 Mar; 2(2):156-160.
2.) Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 2009 Jul 22;302(4):412-23.
<!—
You are visitor number:
#exec cgi=”/cgi-bin/counter.cgi” since April 3, 2007.
—>